4.8 Editorial Material

Nomenclature for cellular plasticity: are the terms as plastic as the cells themselves?

期刊

EMBO JOURNAL
卷 38, 期 19, 页码 -

出版社

WILEY
DOI: 10.15252/embj.2019103148

关键词

-

资金

  1. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [DK078803, DK068471, DK094989, DK105129, DK110406, DK083355]
  2. Alvin J. Siteman Cancer Center/Barnes Jewish Hospital Foundation Cancer Frontier Fund
  3. NIH National Cancer Institute [P30CA091842]
  4. Novartis Institutes for BioMedical Research
  5. Keystone Symposia Director's Fund
  6. Keystone Symposia Future of Science Fund

向作者/读者索取更多资源

It is now recognized that cell identity is more fluid, and tissues more plastic, than previously thought. The plasticity of cells is relevant to diverse fields, most notably developmental and stem cell biology, regenerative medicine, and cancer biology. To date, a comprehensive and uniform nomenclature to define distinct cell states and their injury-induced interconversions has been elusive. The first Keystone Symposium devoted exclusively to cellular plasticity in regeneration and tumorigenesis was held on January 2019 in Keystone, Colorado, and featured a workshop on terminology in the cell plasticity field. Definitions for terms such as plasticity, de- and transdifferentiation, reversion, and paligenosis were discussed. Here, we summarize the content and tenor of the symposium and nomenclature-focused workshop with regard to terms in the field. We outline the challenges with current definitions and recommend best practices and approaches to developing an accurate and acceptable nomenclature in the future.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据